[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) 

# Risk: __Lack of novel treatment options__ (PBN__Risk_2189)

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## List of stakeholders linked to the risk

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [pharmaceutical companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_124.md)

## Property: has_RiskISO_Purpose

* [Well-being](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_1.md)

## Articles mentionning the risk

* [ting_digital_2020](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_278.md)

## Property: has_RiskDescription

Limited availability of effective drugs for treating COVID-19.

## People affected by this risk

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [healthcare providers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_121.md)

## Technologies linked to the risk

* [artificial intelligence (ai)](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1714.md)

## Property: has_RiskType

* [technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

## Property: has_RiskISO_Impact

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Name of the risk

Limited treatment options and increased mortality rates.

## Mitigations of this risk

* [Utilize AI algorithms for drug discovery and development of novel treatments.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2860.md)

## Property: has_RiskGBN

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

